APA (7th ed.) Citation

B, A., R, S., J, L., RJ, A., RE, T., A, S., . . . IA, A. (2026). Recurrent Symptomatic Hemorrhage in Cerebral Cavernous Malformations After Discontinuation of Atorvastatin or Placebo. Journal of the American Heart Association, 15(3), e46943. https://doi.org/10.1161/JAHA.125.046943

Chicago Style (17th ed.) Citation

B, Ali, et al. "Recurrent Symptomatic Hemorrhage in Cerebral Cavernous Malformations After Discontinuation of Atorvastatin or Placebo." Journal of the American Heart Association 15, no. 3 (2026): e46943. https://doi.org/10.1161/JAHA.125.046943.

MLA (9th ed.) Citation

B, Ali, et al. "Recurrent Symptomatic Hemorrhage in Cerebral Cavernous Malformations After Discontinuation of Atorvastatin or Placebo." Journal of the American Heart Association, vol. 15, no. 3, 2026, p. e46943, https://doi.org/10.1161/JAHA.125.046943.